Biomarker for the diagnosis of pulmonary hypertension (PH)

US11275093B2 · kind B2 · utility

Assignees

• CBMED GMBH CENTER FOR BIOMARKER RESEARCH IN MEDICINE · AT
• JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH · AT
• LBI-LVR-LUDWIG BOLTZMANN INSTITUTE LUNG VASCULAR RESEARCH OF THE LUDWIG BOLTZMANN GESELLSCHAFT GMBH · AT
• MEDIZIN MEDIZINISCHE UNIVERSITAT GRAZ · AT

Inventors

• Natalie Bordag · Graz, AT
• Christoph MAGNES · Kumberg, AT
• Sophie Narath · Graz, AT
• Edgar Gander · Graz, AT
• Andrea Olschewski · Graz, AT
• Bence M Nagy · Graz, AT
• Horst Olschewski · Graz, AT

Key dates

• Filing date: Mar 8, 2017
• Grant date: Mar 15, 2022
• Expiry date: Apr 4, 2037

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2800/12
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

The present invention relates to a method of diagnosing pulmonary hypertension (PH) in a patient, a method of monitoring the course of pulmonary hypertension in a patient, a method of determining the severity of pulmonary hypertension in a patient, and a method of differentiating between pulmonary hypertension and at least one condition selected from a group consisting of a disease associated with a risk of developing pulmonary hypertension and metabolic syndrome. In addition, the present invention relates to a kit comprising means for carrying out the above methods.